Dr Boreham’s Crucible: It’s no pain, no gain for this MVP, but can it finally become the GOAT?
No company wants sub-optimal returns on their product – and pain-management house Medical Developments International (ASX:MVP) is no exception. For some years, management has believed that customers undervalued the worth of its flagship product, the first- …